Author
Listed:
- Gregory Hoy
(University of Michigan, School of Public Health)
- Thomas Cortier
(Université Paris Cité INSERM U1332, Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur
Sorbonne Université, Collège Doctoral)
- Hannah E. Maier
(University of Michigan, School of Public Health)
- Guillermina Kuan
(Sustainable Sciences Institute
Centro de Salud Sócrates Flores Vivas, Ministry of Health)
- Roger Lopez
(Sustainable Sciences Institute
Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Laboratorio Nacional de Virología)
- Nery Sanchez
(Sustainable Sciences Institute)
- Sergio Ojeda
(Sustainable Sciences Institute)
- Miguel Plazaola
(Sustainable Sciences Institute)
- Daniel Stadlbauer
(Icahn School of Medicine at Mount Sinai, Department of Microbiology, Icahn School of Medicine at Mount Sinai)
- Abigail Shotwell
(University of Michigan, School of Public Health)
- Angel Balmaseda
(Sustainable Sciences Institute
Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Laboratorio Nacional de Virología)
- Florian Krammer
(Icahn School of Medicine at Mount Sinai, Department of Microbiology, Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai, Center for Vaccine Research and Pandemic Preparedness (C-VaRPP)
Icahn School of Medicine at Mount Sinai, Department of Pathology, Molecular and Cell-Based Medicine
Medical University of Vienna, Ignaz Semmelweis Institute, Interuniversity Institute for Infection Research)
- Simon Cauchemez
(Université Paris Cité INSERM U1332, Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur)
- Aubree Gordon
(University of Michigan, School of Public Health)
Abstract
Immune responses against neuraminidase (NA) and hemagglutinin (HA) are critical for developing effective influenza vaccines, yet their role in influenza transmission remains unclear. We conducted household transmission studies in Managua, Nicaragua, to assess the impact of anti-NA and anti-HA antibodies induced by natural infection on influenza A/H3N2 susceptibility and infectivity. Using mathematical models capturing household transmission dynamics, we found that high pre-existing antibody levels against the HA head (>31, [95% CrI 13–67]), HA stalk (>35, [95% CrI 11–66]), and NA (>31, [95% CrI 12–68]) are associated with reduced susceptibility to infection (relative susceptibility: HA head, 0.63 [95% CrI 0.42–0.98]; HA stalk, 0.66 [95% CrI 0.44–0.99]; NA, 0.49 [95% CrI 0.30–0.76]). HA stalk (>58 [95% CrI: 47–70]) and NA (>27 [95% CrI: 15–43]) are associated with reduced infectivity (relative infectivity: NA, 0.55 [95% CrI: 0.32–0.98], HA stalk 0.53 [95% CrI: 0.27–0.97]). These findings suggest that influenza vaccines designed to elicit NA immunity in addition to HA immunity may not only enhance protection against infection but also reduce onward transmission.
Suggested Citation
Gregory Hoy & Thomas Cortier & Hannah E. Maier & Guillermina Kuan & Roger Lopez & Nery Sanchez & Sergio Ojeda & Miguel Plazaola & Daniel Stadlbauer & Abigail Shotwell & Angel Balmaseda & Florian Kramm, 2025.
"Anti-neuraminidase and anti-HA stalk antibodies reduce the susceptibility to and infectivity of influenza A/H3N2 virus,"
Nature Communications, Nature, vol. 16(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-65283-0
DOI: 10.1038/s41467-025-65283-0
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-65283-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.